SG Americas Securities’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$141K Buy
+20,338
New +$170K ﹤0.01% 2957
2026
Q1
– Sell
-5,518
Closed -$150K – 3807
2025
Q4
$150K Buy
+5,518
New +$137K ﹤0.01% 3052
2025
Q1
– Sell
-7,590
Closed -$125K – 3828
2024
Q4
$125K Buy
+7,590
New +$169K ﹤0.01% 2571

Other funds holding UPB

SG Americas Securities's UPB Position: Q2 2026 in Review

SG Americas Securities opened a new position in Upstream Bio (UPB) in Q2 2026: 20,338 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #2957 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in UPB as recently as Q4 2025.

SG Americas Securities first reported a position in UPB in Q4 2024 and has held it in 3 quarters since. The position peaked at $150K in Q4 2025. 148 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • SG Americas Securities held 20,338 shares of Upstream Bio worth $141K as of Q2 2026.
  • Upstream Bio was a new SG Americas Securities position in Q2 2026.
  • Upstream Bio made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2957 holding.
  • SG Americas Securities first reported a position in Upstream Bio in Q4 2024 and has held it in 3 quarters since.
  • SG Americas Securities's Upstream Bio position peaked at $150K in Q4 2025.
  • 148 funds tracked by Wall St. Rank held Upstream Bio as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.